search
Back to results

Balanced Crystalloid vs. Saline in Children With Septic Shock

Primary Purpose

Septic Shock, Shock

Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Balanced crystalloid solution
0.9%sodium chloride
Sponsored by
All India Institute of Medical Sciences, New Delhi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Septic Shock focused on measuring Normal saline, Multiple electrolyte solution, Septic shock, Children, Hyperchloremia, Acute kidney injury, 0.9% saline, Balanced crystalloid

Eligibility Criteria

2 Months - 15 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children 2 month to ≤ 15 years with features of septic shock - defined as children who have a suspected infection manifested by hypothermia or hyperthermia and have at least two clinical signs of decreased perfusion with or without hypotension

Exclusion Criteria:

  • Children receiving fluid boluses before enrollment
  • Children with cardiogenic shock
  • Known patient with chronic kidney disease with baseline deranged renal function (eGFR < 90 ml/1.73 m2/min)
  • Severe malnutrition
  • Children whose parents refuse to give an informed consent

Sites / Locations

  • All India Institute of Medical Sciences
  • St Johns Medical College and Hospital
  • PGIMER
  • JIPMER

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Balanced crystalloid or multiple electrolyte solution group

0.9% saline or saline group

Arm Description

After enrollment, a fluid bolus comprising of 'multiple electrolyte solution (Plasma-Lyte P)' solution at a dose of 20 ml/kg over 15-20 minutes (recommended) with careful monitoring for features of fluid overload would be administered to each child. Fluid resuscitation will be targeted at achieving the therapeutic end points as given in study definitions. After this the management protocol will be as per recommendations of the American College of Critical Care Medicine 2017 for septic shock in children.

After enrollment, a fluid bolus comprising of 'saline' solution at a dose of 20 ml/kg over 15-20 minutes (recommended) with careful monitoring for features of fluid overload would be administered to each child. Fluid resuscitation will be targeted at achieving the therapeutic end points as given in study definitions. After this the management protocol will be as per recommendations of the American College of Critical Care Medicine 2017 for septic shock in children.

Outcomes

Primary Outcome Measures

New or progressive acute kidney injury defined as increase in serum creatinine by > 0.3mg/dL within 48 hours or to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours
Incidence of new or progressive AKI in first 7 days after randomization/ intervention

Secondary Outcome Measures

Proportion of patients with serum chloride levels > 108 meq/L at admission, 6, 24, 48 and 72 hours
Incidence of hyperchloremia
Number of fluid boluses received in the first 6 hours after randomization
Total number of fluid boluses received in the first 6 hours after randomization/intervention
Total fluids received in the first 24 hours, 24-48 hours and 48-72hrs in ml/kg after randomization
Total fluids received in first 24 hours, 24-48 hours and 48-72 hours
Mortality (serious adverse event)
Death during ICU course
Time to resolution of AKI
Time taken for resolution of AKI
SOFA scores at 24 and 48 hours after randomization
Comparison of SOFA scores in both groups at 24 hours and 48 hours after randomization
PELOD scores at 24 and 48 hours after randomization
Comparison of PELOD scores in both groups at 24 hours and 48 hours after randomization
Incidence of metabolic acidosis at 6, 24, 48 and 72 hours after randomization
Comparison of number of children in both groups with acidosis at 6, 24, 48 and 72 hours after randomization

Full Information

First Posted
March 1, 2016
Last Updated
December 6, 2021
Sponsor
All India Institute of Medical Sciences, New Delhi
Collaborators
Postgraduate Institute of Medical Education and Research, Jawaharlal Institute of Postgraduate Medical Education & Research, St Johns Medical College Hospital, Bangalore, India
search

1. Study Identification

Unique Protocol Identification Number
NCT02835157
Brief Title
Balanced Crystalloid vs. Saline in Children With Septic Shock
Official Title
Multiple Electrolyte Solution vs. Saline in Pediatric Septic Shock
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
January 15, 2020 (Actual)
Study Completion Date
January 15, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
All India Institute of Medical Sciences, New Delhi
Collaborators
Postgraduate Institute of Medical Education and Research, Jawaharlal Institute of Postgraduate Medical Education & Research, St Johns Medical College Hospital, Bangalore, India

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Fluid resuscitation is the cornerstone of pediatric shock management; current practices of fluid resuscitation in children are not evidence based. Normal saline is the preferred crystalloid recommended during initial resuscitation in shock, as the incidence of hyponatremia is lower with normal saline compared to all other fluids available and commonly used. However, normal saline has its own set of undesired physicochemical actions. Emerging data strongly indicate the increased incidence of hyperchloremia, metabolic acidosis and consequently, acute kidney injury associated with infusion of large volumes of normal saline. Balanced salt solutions or crystalloids, which have composition resembling plasma but lower chloride concentrations than normal saline, clearly decrease the risk of hyperchloremia and metabolic acidosis in adult as well as pediatric studies when used during the peri-operative period. The results favored balanced solutions in comparison to normal saline. Recent systematic reviews comparing balanced or buffered versus non-buffered fluids for surgery in adults favored the former solution as the metabolic derangements were less with the use of this type of fluid. In adult patients, the two solutions have been compared in various other settings as well such as in traumatic brain injury and in shock. The results favored balanced solutions in comparison to normal saline. However, in the non-surgical setting there is a paucity of evidence on the use of these solutions in children with shock and more evidence needs to be generated to support or refute the use of this fluid as compared to normal saline. Given this background, the investigators decided to compare the effect of two solutions on the incidence of acute kidney injury in children resuscitated with either of the two fluids. Children receiving at least one fluid bolus at 20 ml/kg in the first hour would be enrolled and followed up for the proposed outcome variables. The investigators plan to enroll 708 patients over a period of 3 years. The investigators believe that the proposed study will provide answer to the research question of which of the fluids could be preferred for resuscitation.
Detailed Description
Background Fluid resuscitation is the cornerstone of pediatric shock management; current practices of fluid resuscitation in children are not evidence based. Emerging data strongly indicate the increased incidence of hyperchloremic metabolic acidosis and consequently, acute kidney injury associated with infusion of large volumes of normal saline in critically ill adults in shock. Balanced salt solutions or crystalloids, which have composition resembling plasma but lower chloride concentrations than normal saline, have shown to decrease the risk of hyperchloremia and metabolic acidosis in adult as well as pediatric studies when used during the peri-operative period. In adult patients, the two solutions have been compared in various other settings as well such as in traumatic brain injury and in shock. The results favored balanced solutions in comparison to normal saline. However, in the non-surgical setting there is a paucity of evidence on the use of these solutions in children with shock and more evidence needs to be generated to support or refute the use of this fluid as compared to normal saline. Objectives Primary To examine if use of 'balanced crystalloids (multiple electrolyte solution)" results in lower incidence of new or progressive Acute kidney injury (defined as increase in serum creatinine by > 0.3mg/dL within 48 hours or to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours) in the first seven days after initial fluid resuscitation as compared to saline. Secondary To evaluate the difference if any, between two fluid types with regard to the following secondary objectives such as: Incidence of hyperchloremia (defined as serum chloride levels >108 mEq/L) at 6, 24, 48 and 72 hrs of fluid resuscitation. Incidence of metabolic acidosis at 6, 24, 48 and 72 hrs of fluid resuscitation. Requirement of fluid boluses in first 6 hrs and total fluids in first 24 hours, 48 hours and 72 hours. Proportion of patients achieving the pre-determined therapeutic end points at 6, 24, 48 hours and 72 hours after fluid resuscitation. Need for inotrope therapy in first 7 days. Change in SOFA scores and PELOD scores at 24 hours and 48 hours. Time to resolution of AKI. In- ICU mortality rates. Ventilator free days, ICU free days and Hospital free days. Site of study Pediatric emergency and PICU, Department of Pediatrics, All India Institute of medical Sciences,New Delhi Other sites PGIMER, Chandigarh, JIPMER Puducherry and St Johns Medical College Bengaluru Study Design Randomized controlled trial (safety and superiority for kidney injury). Multicenter trial. Study Duration 3 years Study definitions Septic shock is defined as children who have a suspected infection manifested by hypothermia or hyperthermia and have at least two clinical signs of decreased perfusion with or without hypotension such as decreased mental status, prolonged capillary refill of >2 secs (cold shock) or flash capillary refill (warm shock), diminished (cold shock) or bounding (warm shock) peripheral pulses, mottled cool extremities (cold shock), or decreased urine output of <1 ml/kg/hr). Therapeutic end points Normal heart rate Appropriate-for-age mean arterial pressure (MAP) measured non-invasively; Normal pulses with no difference between peripheral and central pulses, warm extremities; Capillary refill time <2 seconds; Normal mental status; Urine output ≥ 1mL/kg/hr, Hyperchloremia: Defined as serum chloride value of >108 meq/L, based on our laboratory cut off of 98-108 meq/L Metabolic acidosis: pH of less than 7.35 with serum bicarbonate < 24 meq/L with low to normal pCO2 (<40 mm Hg) Acute kidney injury: An abrupt (within 48-hr) reduction in kidney function defined as an absolute increase in serum creatinine of more than or equal to 0.3 mg/dl, an increase in serum creatinine of more than or equal to 1.5 fold from the value preceding the abnormal value, or reduction in urine output (oliguria of less than 0.5 ml/kg per hour for >6-hr). Enrollment All children with features of shock as per standard definitions will be screened for eligibility. Of these, children who require at least one fluid bolus of 20 ml/kg will be enrolled. The eligible participants would be enrolled after obtaining informed consent from one of the parents. Randomization Once enrolled, the participants would be randomized into 2 groups. 'MES' or 'study group' will receive the balanced fluids and 'saline' or 'control group' will receive 0.9% saline. Process of randomization will be done by an investigator who will have no further role in collecting the baseline variables, applying intervention or analysis of outcome(s). Block randomization will be done in varying block sizes of 2 to 8. The random number table generated from computer software would be used for this purpose. Sample size estimation The investigators calculated that a sample size of 354 patients in each group (708 total) would be required to detect an absolute reduction in incidence of AKI from 25% (current incidence in children with shock in the unit) to 15% assuming a two-sided α level of 0.05 and a statistical power of 90%. The sample size was calculated using Stata 11. The investigators expect the required sample size to be collected within 3 years period in the three centers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock, Shock
Keywords
Normal saline, Multiple electrolyte solution, Septic shock, Children, Hyperchloremia, Acute kidney injury, 0.9% saline, Balanced crystalloid

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The enrolled children will be randomized to either balanced crystalloid (Plasma-Lyte A or multiple electrolyte solutions or MES group) or 0.9% saline (saline group).
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Serially numbered, sealed, opaque pouches containing 10 bags of 500 ml of either MES or saline each will be kept at the study site. Each of the 500 ml bags will be packed in sealed opaque covers inside the pouches as well.The research staff will pick the bag of fluids kept as per allocation sequence and start the bolus in the patient.
Allocation
Randomized
Enrollment
708 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Balanced crystalloid or multiple electrolyte solution group
Arm Type
Experimental
Arm Description
After enrollment, a fluid bolus comprising of 'multiple electrolyte solution (Plasma-Lyte P)' solution at a dose of 20 ml/kg over 15-20 minutes (recommended) with careful monitoring for features of fluid overload would be administered to each child. Fluid resuscitation will be targeted at achieving the therapeutic end points as given in study definitions. After this the management protocol will be as per recommendations of the American College of Critical Care Medicine 2017 for septic shock in children.
Arm Title
0.9% saline or saline group
Arm Type
Active Comparator
Arm Description
After enrollment, a fluid bolus comprising of 'saline' solution at a dose of 20 ml/kg over 15-20 minutes (recommended) with careful monitoring for features of fluid overload would be administered to each child. Fluid resuscitation will be targeted at achieving the therapeutic end points as given in study definitions. After this the management protocol will be as per recommendations of the American College of Critical Care Medicine 2017 for septic shock in children.
Intervention Type
Drug
Intervention Name(s)
Balanced crystalloid solution
Other Intervention Name(s)
Plasma-Lyte A 148, Multiple electrolyte solution
Intervention Description
Multiple electrolyte solution as boluses would be administered.
Intervention Type
Drug
Intervention Name(s)
0.9%sodium chloride
Other Intervention Name(s)
Saline
Intervention Description
saline as boluses would be administered
Primary Outcome Measure Information:
Title
New or progressive acute kidney injury defined as increase in serum creatinine by > 0.3mg/dL within 48 hours or to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours
Description
Incidence of new or progressive AKI in first 7 days after randomization/ intervention
Time Frame
From the time of randomization/intervention to 7 days of admission
Secondary Outcome Measure Information:
Title
Proportion of patients with serum chloride levels > 108 meq/L at admission, 6, 24, 48 and 72 hours
Description
Incidence of hyperchloremia
Time Frame
At 6, 24, 48 and 72 hours after randomization
Title
Number of fluid boluses received in the first 6 hours after randomization
Description
Total number of fluid boluses received in the first 6 hours after randomization/intervention
Time Frame
From the time of randomization to 6 hours
Title
Total fluids received in the first 24 hours, 24-48 hours and 48-72hrs in ml/kg after randomization
Description
Total fluids received in first 24 hours, 24-48 hours and 48-72 hours
Time Frame
From the time of randomization to 72 hours
Title
Mortality (serious adverse event)
Description
Death during ICU course
Time Frame
From the time of randomization till death or discharge from ICU, whichever came first assessed upto 100 days
Title
Time to resolution of AKI
Description
Time taken for resolution of AKI
Time Frame
From the time of onset of AKI after randomization till death or discharge from hospital, whichever came first assessed upto 100 days
Title
SOFA scores at 24 and 48 hours after randomization
Description
Comparison of SOFA scores in both groups at 24 hours and 48 hours after randomization
Time Frame
At 24 and 48 hours after randomization
Title
PELOD scores at 24 and 48 hours after randomization
Description
Comparison of PELOD scores in both groups at 24 hours and 48 hours after randomization
Time Frame
At 24 and 48 hours after randomization
Title
Incidence of metabolic acidosis at 6, 24, 48 and 72 hours after randomization
Description
Comparison of number of children in both groups with acidosis at 6, 24, 48 and 72 hours after randomization
Time Frame
At admission and at 6, 24, 48 and 72 hours after randomization
Other Pre-specified Outcome Measures:
Title
Safety outcome 1
Description
New or progressive AKI requiring dialysis (serious adverse event)
Time Frame
From the time of randomization/intervention to 7 days of admission
Title
Safety outcome 2
Description
IN-ICU mortality in patients with AKI (serious adverse event)
Time Frame
From the time of randomization/intervention to mortality
Title
Safety outcome 3
Description
Infusion related adverse events- fever, rash, extravasation, hypervolemia/fluid overload
Time Frame
From the time of initiating the bolus to its completion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Months
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children 2 month to ≤ 15 years with features of septic shock - defined as children who have a suspected infection manifested by hypothermia or hyperthermia and have at least two clinical signs of decreased perfusion with or without hypotension Exclusion Criteria: Children receiving fluid boluses before enrollment Children with cardiogenic shock Known patient with chronic kidney disease with baseline deranged renal function (eGFR < 90 ml/1.73 m2/min) Severe malnutrition Children whose parents refuse to give an informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jhuma Sankar, MD Ped
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sushil K Kabra, MD Ped
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Rakesh Lodha, MD Ped
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Study Director
Facility Information:
Facility Name
All India Institute of Medical Sciences
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110029
Country
India
Facility Name
St Johns Medical College and Hospital
City
Bengaluru
State/Province
Karnataka
ZIP/Postal Code
560034
Country
India
Facility Name
PGIMER
City
Chandigarh
Country
India
Facility Name
JIPMER
City
Puducherry
ZIP/Postal Code
605006
Country
India

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual patient data will not be shared

Learn more about this trial

Balanced Crystalloid vs. Saline in Children With Septic Shock

We'll reach out to this number within 24 hrs